SEC Form 5/A · accession 0001185185-15-001225
IGC Pharma, Inc. · IGC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 5/A). It replaces an earlier filing for the same period.
Reporting owner
Richard K Prins
Director
Period of report
Mar 31, 2014
Accepted (ET)
May 13, 2015 · 8:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326205
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | May 31, 2013 | G | 5,000 | $0.00 | D | 100,000 | D | |
| Common stock | Jun 18, 2013 | G | 25,000 | $0.00 | D | 75,000 | D | |
| Common stock | Oct 17, 2013 | G | 15,000 | $0.00 | D | 60,000 | D | |
| Common stock | Feb 28, 2014 | G | 1,500 | $0.00 | D | 58,500 | D | |
| Common stock | Mar 7, 2014 | G | 1,500 | $0.00 | D | 57,000 | D | |
| Common stock | Mar 14, 2014 | G | 1,500 | $0.00 | D | 55,500 | D | |
| Common stock | Mar 21, 2014 | G | 1,500 | $0.00 | D | 54,000 | D | |
| Common stock | Mar 28, 2014 | G | 1,500 | $0.00 | D | 52,500 | D |
Table II — derivative securities
No Table II lines on this filing.